Faeth Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Faeth Therapeutics Total Assets Growth & History (FTH)
Faeth Therapeutics's total assets was $22.9M for fiscal 2025.
View full Faeth Therapeutics company overviewFaeth Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $22.9M | −$22.5M | −49.51% |
| 2024 | 2024-12-31 | $45.4M | −$29.0M | −39.01% |
| 2023 | 2023-12-31 | $74.4M | −$44.0M | −37.17% |
| 2022 | 2022-12-31 | $118.4M | −$34.9M | −22.74% |
| 2021 | 2021-12-31 | $153.2M | $131.8M | +615.07% |
| 2020 | 2020-12-31 | $21.4M | — | — |
Faeth Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $189.3M | $157.5M | +495.62% |
| Q1 2026 | 2026-03-31 | $205.4M | $167.1M | +436.62% |
| Q4 2025 | 2025-12-31 | $22.9M | −$22.5M | −49.51% |
| Q3 2025 | 2025-09-30 | $27.6M | −$25.7M | −48.19% |
| Q2 2025 | 2025-06-30 | $31.8M | −$28.0M | −46.85% |
| Q1 2025 | 2025-03-31 | $38.3M | −$28.4M | −42.61% |
| Q4 2024 | 2024-12-31 | $45.4M | −$29.0M | −39.01% |
| Q3 2024 | 2024-09-30 | $53.3M | −$28.4M | −34.78% |
| Q2 2024 | 2024-06-30 | $59.8M | −$29.8M | −33.25% |
| Q1 2024 | 2024-03-31 | $66.7M | −$41.2M | −38.21% |
| Q4 2023 | 2023-12-31 | $74.4M | −$44.0M | −37.17% |
| Q3 2023 | 2023-09-30 | $81.7M | −$47.1M | −36.60% |
| Q2 2023 | 2023-06-30 | $89.6M | −$48.5M | −35.10% |
| Q1 2023 | 2023-03-31 | $107.9M | −$42.1M | −28.06% |
| Q4 2022 | 2022-12-31 | $118.4M | −$34.9M | −22.74% |
| Q3 2022 | 2022-09-30 | $128.8M | −$32.4M | −20.12% |
| Q2 2022 | 2022-06-30 | $138.0M | −$29.7M | −17.70% |
| Q1 2022 | 2022-03-31 | $150.0M | −$24.4M | −14.01% |
| Q4 2021 | 2021-12-31 | $153.2M | $131.8M | +615.07% |
| Q3 2021 | 2021-09-30 | $161.2M | — | — |
| Q2 2021 | 2021-06-30 | $167.7M | — | — |
| Q1 2021 | 2021-03-31 | $174.5M | — | — |
| Q4 2020 | 2020-12-31 | $21.4M | — | — |
Faeth Therapeutics total assets trends
Over the last five fiscal years, Faeth Therapeutics's total assets increased from $21.4M to $22.9M, a change of $1.5M. The latest reported quarter, Q2 2026, shows $189.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Faeth Therapeutics source filings ↗